Microneedling and Serum for Acne

Age: 18 - 65

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 2 & 3

Waitlist Available

Sponsor: Equipmed USA LLC

No Placebo Group

Prior Safety Data

Trial Summary

What is the purpose of this trial?

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

Eligibility Criteria

This trial is for individuals with acne who are looking to improve their skin condition. Specific eligibility criteria have not been provided, so it's best to contact the study organizers for detailed requirements.

Inclusion Criteria

Fitzpatrick skin phototype I to VI

I haven't treated my acne with any methods for the last month.

I am a woman aged between 18 and 45.

Exclusion Criteria

Subjects known to have bleeding and clotting disorders (self-declared)

I currently have an active cold sore infection.

Subjects known to have connective tissue disorders

Treatment Details

Interventions

• Dermapen 4™ (Procedure)

Trial Overview The effectiveness of Dermapen 4™ microneedling device in combination with MG-CLR serum is being tested over a period of 12 weeks to treat acne.

Participant Groups

Group I: A single arm, full face clinical study. Experimental Treatment 1 Intervention

Dermapen 4 in conjunction with MG-CLR serum

Who Is Running the Clinical Trial?

Equipmed USA LLC

Lead Sponsor

Trials

1

Recruited

10+